Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Intervening to Prevent Contextual Errors in Medical Decision Making
Intervening to Prevent Contextual Errors in Medical Decision Making
Status: Enrolling
Updated:  7/12/2012
Jesse Brown VAMC
mi
from
Chicago, IL
Intervening to Prevent Contextual Errors in Medical Decision Making
Intervening to Prevent Contextual Errors in Medical Decision Making
Status: Enrolling
Updated: 7/12/2012
Jesse Brown VAMC
mi
from
Chicago, IL
Click here to add this to my saved trials
Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD
Status: Enrolling
Updated:  7/13/2012
North Shore - LIJ Health System, Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD
Status: Enrolling
Updated: 7/13/2012
North Shore - LIJ Health System, Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD
Status: Enrolling
Updated:  7/13/2012
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD
Status: Enrolling
Updated: 7/13/2012
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD
Status: Enrolling
Updated:  7/13/2012
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD
Status: Enrolling
Updated: 7/13/2012
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia
Phase I, Randomized, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 579 in Healthy Adult Subjects and Patients With Stable Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  7/13/2012
Clinical Research Facility
mi
from
San Diego, CA
First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia
Phase I, Randomized, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 579 in Healthy Adult Subjects and Patients With Stable Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 7/13/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia
A Pilot, Open-Label, Non-Randomized, Single Ascending Dose, Safety and Pharmacokinetic Trial With Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Chronic, Stable Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  7/16/2012
Glendale Adventist Medical Center
mi
from
Glendale, CA
A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia
A Pilot, Open-Label, Non-Randomized, Single Ascending Dose, Safety and Pharmacokinetic Trial With Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Chronic, Stable Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 7/16/2012
Glendale Adventist Medical Center
mi
from
Glendale, CA
Click here to add this to my saved trials
Measurement of Joint Attention Fluency
Measurement of Joint Attention Fluency
Status: Enrolling
Updated:  7/16/2012
The Vista School
mi
from
Hershey, PA
Measurement of Joint Attention Fluency
Measurement of Joint Attention Fluency
Status: Enrolling
Updated: 7/16/2012
The Vista School
mi
from
Hershey, PA
Click here to add this to my saved trials
Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
Cannabinoid Receptor Antagonist Treatment of Cognitive Dysfunction in Schizophrenia
Status: Enrolling
Updated:  7/17/2012
Yale University
mi
from
New Haven, CT
Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
Cannabinoid Receptor Antagonist Treatment of Cognitive Dysfunction in Schizophrenia
Status: Enrolling
Updated: 7/17/2012
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Status: Enrolling
Updated:  7/18/2012
Hartford Dispensary
mi
from
Hartford, CT
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Status: Enrolling
Updated: 7/18/2012
Hartford Dispensary
mi
from
Hartford, CT
Click here to add this to my saved trials
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Status: Enrolling
Updated:  7/19/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Status: Enrolling
Updated: 7/19/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Cardiovascular Risk Markers in Veterans With Post Traumatic Stress Disorder
Cardiovascular Risk Markers in Veterans With PTSD
Status: Enrolling
Updated:  7/23/2012
VASDHS
mi
from
San Diego, CA
Cardiovascular Risk Markers in Veterans With Post Traumatic Stress Disorder
Cardiovascular Risk Markers in Veterans With PTSD
Status: Enrolling
Updated: 7/23/2012
VASDHS
mi
from
San Diego, CA
Click here to add this to my saved trials
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Status: Enrolling
Updated:  7/25/2012
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Status: Enrolling
Updated: 7/25/2012
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Pramipexole as a Treatment for Cocaine Dependence
Pramipexole as a Treatment for Cocaine Dependence
Status: Enrolling
Updated:  7/25/2012
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Pramipexole as a Treatment for Cocaine Dependence
Pramipexole as a Treatment for Cocaine Dependence
Status: Enrolling
Updated: 7/25/2012
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder
Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder
Status: Enrolling
Updated:  7/25/2012
Denver VA Medical Center
mi
from
Denver, CO
Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder
Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder
Status: Enrolling
Updated: 7/25/2012
Denver VA Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Antidepressant Therapy in Treating Bipolar Type II Major Depression
Treatment of Bipolar Type II Major Depression
Status: Enrolling
Updated:  7/26/2012
Depression Research Unit - University of Pennsylvania
mi
from
Philadelphia, PA
Antidepressant Therapy in Treating Bipolar Type II Major Depression
Treatment of Bipolar Type II Major Depression
Status: Enrolling
Updated: 7/26/2012
Depression Research Unit - University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cortisol Augmentation of Prolonged Exposure Therapy
Cortisol Augmentation of Prolonged Exposure Therapy
Status: Enrolling
Updated:  7/26/2012
James J. Peters Veterans Affairs Medical Center
mi
from
Bronx, NY
Cortisol Augmentation of Prolonged Exposure Therapy
Cortisol Augmentation of Prolonged Exposure Therapy
Status: Enrolling
Updated: 7/26/2012
James J. Peters Veterans Affairs Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Delirium in the Emergency Department and Its Extension Into Hospitalization
Status: Enrolling
Updated:  7/26/2012
Vanderbilt University Medical Center
mi
from
Nashville, TN
Delirium in the Emergency Department and Its Extension Into Hospitalization
Status: Enrolling
Updated: 7/26/2012
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Prevention of Relapse & Recurrence of Bipolar Depression
Prevention of Relapse & Recurrence of Bipolar Depression
Status: Enrolling
Updated:  7/27/2012
Rush University Medical Center
mi
from
Chicago, IL
Prevention of Relapse & Recurrence of Bipolar Depression
Prevention of Relapse & Recurrence of Bipolar Depression
Status: Enrolling
Updated: 7/27/2012
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Prevention of Relapse & Recurrence of Bipolar Depression
Prevention of Relapse & Recurrence of Bipolar Depression
Status: Enrolling
Updated:  7/27/2012
Depression Research Unit
mi
from
Philadelphia, PA
Prevention of Relapse & Recurrence of Bipolar Depression
Prevention of Relapse & Recurrence of Bipolar Depression
Status: Enrolling
Updated: 7/27/2012
Depression Research Unit
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Family Check-Up for Adolescents and Siblings
Effects of the Family Check-Up on Adolescents With Alcohol-Related Events and Their Siblings
Status: Enrolling
Updated:  7/28/2012
Brown University
mi
from
Providence, RI
Family Check-Up for Adolescents and Siblings
Effects of the Family Check-Up on Adolescents With Alcohol-Related Events and Their Siblings
Status: Enrolling
Updated: 7/28/2012
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Individual and Family Motivational Interviews for Substance Using Truant Teens
Individual and Family Motivational Interviews for Substance Using Truant Teens
Status: Enrolling
Updated:  7/28/2012
Brown University
mi
from
Providence, RI
Individual and Family Motivational Interviews for Substance Using Truant Teens
Individual and Family Motivational Interviews for Substance Using Truant Teens
Status: Enrolling
Updated: 7/28/2012
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Escitalopram Neuroimaging Supplement
Cerebral Metabolic Correlates of Treatment Response to Escitalopram in Body Dysmorphic Disorder
Status: Enrolling
Updated:  8/1/2012
OCD & Related Disorders Clinic
mi
from
Boston, MA
Escitalopram Neuroimaging Supplement
Cerebral Metabolic Correlates of Treatment Response to Escitalopram in Body Dysmorphic Disorder
Status: Enrolling
Updated: 8/1/2012
OCD & Related Disorders Clinic
mi
from
Boston, MA
Click here to add this to my saved trials
A Pilot Study of Deep Brain Stimulation of the Amygdala for Treatment-Refractory Combat Post-Traumatic Stress Disorder
A Pilot Study to Examine Deep Brain Stimulation (DBS) in the Basolateral Nucleus (BLn) of the Amygdala for the Management of Symptoms in Veterans With Chronic and Treatment-Refractory Combat-related Post-Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/2/2012
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
A Pilot Study of Deep Brain Stimulation of the Amygdala for Treatment-Refractory Combat Post-Traumatic Stress Disorder
A Pilot Study to Examine Deep Brain Stimulation (DBS) in the Basolateral Nucleus (BLn) of the Amygdala for the Management of Symptoms in Veterans With Chronic and Treatment-Refractory Combat-related Post-Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/2/2012
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)
Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)
Status: Enrolling
Updated:  8/3/2012
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)
Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)
Status: Enrolling
Updated: 8/3/2012
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Couples Therapy for Alcoholic Patients
Behavioral Couples Group Therapy for Alcholic Patients: Clinical and Cost Outcomes
Status: Enrolling
Updated:  8/6/2012
AdCare Hospital of Worcester Inc.
mi
from
Worcester, MA
Couples Therapy for Alcoholic Patients
Behavioral Couples Group Therapy for Alcholic Patients: Clinical and Cost Outcomes
Status: Enrolling
Updated: 8/6/2012
AdCare Hospital of Worcester Inc.
mi
from
Worcester, MA
Click here to add this to my saved trials
Behavioral Couples Therapy for Female Drug-Abusing Patients
Behavioral Couples Therapy for Female Drug-Abusing Patients
Status: Enrolling
Updated:  8/7/2012
AdCare Hospital of Worcester Inc.
mi
from
Worcester, MA
Behavioral Couples Therapy for Female Drug-Abusing Patients
Behavioral Couples Therapy for Female Drug-Abusing Patients
Status: Enrolling
Updated: 8/7/2012
AdCare Hospital of Worcester Inc.
mi
from
Worcester, MA
Click here to add this to my saved trials
Progesterone for Postpartum Cocaine Relapse
Progesterone for Postpartum Cocaine Relapse
Status: Enrolling
Updated:  8/7/2012
Yale School of Medicine
mi
from
New Haven, CT
Progesterone for Postpartum Cocaine Relapse
Progesterone for Postpartum Cocaine Relapse
Status: Enrolling
Updated: 8/7/2012
Yale School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Exercise as Alcohol Use Disorders Intervention for Non-Treatment Seeking Adults
Exercise as Alcohol Use Disorders Intervention for Non-Treatment Seeking Adults
Status: Enrolling
Updated:  8/8/2012
Saint Louis University
mi
from
St. Louis, MO
Exercise as Alcohol Use Disorders Intervention for Non-Treatment Seeking Adults
Exercise as Alcohol Use Disorders Intervention for Non-Treatment Seeking Adults
Status: Enrolling
Updated: 8/8/2012
Saint Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Specialized Treatment Early in Psychosis (STEP)
Randomized Trial of Usual Care Versus Specialized, Phase-specific Care in the Public Sector for First Episode Psychosis.
Status: Enrolling
Updated:  8/9/2012
Connecticut Mental Health Center
mi
from
New Haven, CT
Specialized Treatment Early in Psychosis (STEP)
Randomized Trial of Usual Care Versus Specialized, Phase-specific Care in the Public Sector for First Episode Psychosis.
Status: Enrolling
Updated: 8/9/2012
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Birmingham, AL
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Overland Park, KA
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Baltimore, MD
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Boston, MA
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Newark, NJ
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
A Phase 4, Pilot, Open-label Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Status: Enrolling
Updated:  8/29/2012
Friends Research Institute
mi
from
Baltimore, MD
A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
A Phase 4, Pilot, Open-label Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Status: Enrolling
Updated: 8/29/2012
Friends Research Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 001
mi
from
Dothan, AL
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 001
mi
from
Dothan, AL
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site
mi
from
Phoenix, AZ
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 055
mi
from
Tucson, AZ
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 055
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 077
mi
from
Little Rock, AR
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 077
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 054
mi
from
Glendale, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 054
mi
from
Glendale, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 109
mi
from
Imperial, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 109
mi
from
Imperial, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 17
mi
from
Los Angeles, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 17
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 021
mi
from
San Francisco, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 021
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 073
mi
from
Santa Ana, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 073
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative site 074
mi
from
Santa Ana, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative site 074
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site
mi
from
Oceanside, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 037
mi
from
Boulder, CO
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 037
mi
from
Boulder, CO
Click here to add this to my saved trials